Literature DB >> 24947803

Association of genetic variants with non-alcoholic fatty liver disease in an urban Sri Lankan community.

Anuradhani Kasturiratne1, Koichi Akiyama, Madunil A Niriella, Fumihiko Takeuchi, Masato Isono, Anuradha S Dassanayake, Arjuna P de Silva, Rajitha A Wickremasinghe, Norihiro Kato, Hithanadura J de Silva.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24947803     DOI: 10.1111/liv.12624

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  4 in total

1.  A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations.

Authors:  Zhi-Tao Zhang; Wen-Xu Qi; Cai-Xia Liu; Shao-Wei Yin; Yan Zhao; Jesse Li-Ling; Yuan Lv
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

2.  Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program.

Authors:  Rohan C Siriwardana; Madunil Anuk Niriella; Anuradha Supun Dassanayake; Chandika Anuradha Habarakada Liyanage; Bhagya Gunetilleke; Hithanadura Janaka de Silva
Journal:  Indian J Gastroenterol       Date:  2016-05-04

Review 3.  Nonalcoholic Fatty Liver Disease: Identifying the Disease Burden in Sri Lanka.

Authors:  Anuradha S Dassanayake
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

4.  Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.

Authors:  Madunil Anuk Niriella; Anuradhani Kasturiratna; Thulani Beddage; Dileepa Senajith Ediriweera; Shamila Thivanshi De Silva; K Ruwan Perera; Chamila Erandaka Subasinghe; S Kuleesha Kodisinghe; T Chathura Piyaratna; Vithiya Rishikesawan; Anuradha Supun Dassanayaka; Arjuna Priyadarshin De Silva; Arunasalam Pathmeswaran; Ananda Rajitha Wickramasinghe; Norihiro Kato; Hithanadura Janaka de Silva
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.